Red Cat Holdings enters September with one of the most extreme short-side setups in small-cap defense — 26% of the float shorted, zero shares left to borrow, and a Street that just split sharply on how to value it.
The lending market tells the starkest part of the story. Availability has been at 0% — meaning every share in the lending pool is already out on loan — for all but two days of the past six weeks. Cost to borrow is modest at 1.75%, up roughly 24% on the week, but the real signal is the absolute absence of new borrow: anyone wanting to add short exposure simply cannot. With short interest running at 26.2% of the free float and the ORTEX short score ticking higher to 70.7 — its highest level in the observed window — the positioning is unambiguously crowded. Yet crowded shorts with no route in or out creates its own tension: it doesn't make the trade wrong, but it does make it illiquid. Options tell a calmer story. The put/call ratio of 0.35 is barely above its 20-day average and well below the 52-week high of 0.53, meaning options traders are not particularly defensive despite the acute borrow squeeze. That divergence is worth noting.
The Street landed on opposite poles this week. Piper Sandler opened coverage with a Neutral rating and a $9 target — almost exactly where the stock trades now. One day earlier, Evercore ISI started with Outperform and a $15 target. The gap is not subtle. Needham still carries a Buy from August 7 but trimmed its target from $20 to $15 after the last earnings print. HC Wainwright holds at Buy and $20. Roth Capital, initiating in June, went to $25. The consensus aggregates to a hold with a mean target of $16.75, implying roughly double the current price of $8.25 — but that average masks a genuine debate rather than lazy consensus. Bulls cite the U.S. Army SRR Program of Record ramp, a $150–180M revenue target, and exceptional EPS momentum that ranks in the 98th percentile on a 30-day basis. Bears point to widening net losses, rising operating costs, execution risk in international expansion, and competition from AeroVironment, Northrop, and L3Harris. The price-to-book sits near 3.5x after a 30-day jump of nearly one full turn, reflecting the stock's 10% gain over the past month even as it gave back 9% this week.
The most recent insider activity leans in one direction: director Nicholas Liuzza sold 65,000 shares at $8.50 on August 28 — a $552,500 open-market sale with no 10b5-1 plan attached. That is the only insider transaction in the past 90 days with a disclosed value, and it ran at a price slightly above where the stock ended the week. It is a single data point, but discretionary director selling into a short squeeze backdrop is a fact worth having. On the institutional side, State Street filed a 13G in August disclosing an 8.2% stake, up from 5.5%, and Hood River Capital Management made a first-time 13G filing on August 14 at 7.16% — two meaningful passive accumulations within the past month. BlackRock holds 7.3%, raised from 5.1%. Vanguard, which previously held 5%, has since filed showing zero shares. The passive bid is real, but so is Vanguard's exit.
Peer defense names had a rough week alongside RCAT. KTOS fell 6.3% and AIRO dropped 10.3%. LUNR lost 11.3%. The weakness was sector-wide rather than stock-specific, which slightly dilutes the read-through from RCAT's own 9% decline. One outlier: DPRO surged 24% on the week, showing the space can still produce sharp counter-trend moves.
The next earnings event is scheduled for November 6. With borrow fully locked, short interest entrenched at 26% of float, a Piper initiation anchoring expectations near current prices, and a director selling at $8.50 last week, the key question heading into autumn is whether contract news or quarterly revenue figures are sufficient to shift the Evercore bull case from target to trade — or whether the Piper Neutral proves the more accurate frame for a stock priced for execution it has yet to deliver at scale.
See the live data behind this article on ORTEX.
Open RCAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
